Christopher Martell

CADL

Christopher Martell serves as Director at Candel Therapeutics, Inc. (CADL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$1.05M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$1.05M

Companies Traded

CADL

Active Period

Jul 2021 – Dec 2022

2 total trades

Most Recent

Buy CADL

Dec 8, 2022 · $51.1K

Christopher Martell's Insider Trading at Candel Therapeutics, Inc. (CADL)

Buys

2 · $1.05M

Sells

0 · $0.00

Total Shares Bought

152,000

Total Shares Sold

CADL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 8, 2022	Buy	27,000	$1.89	$51.1K	0
Jul 29, 2021	Buy	125,000	$8.00	$1.00M	0

Related Insiders

Francesca Barone

officer: Chief Scientific Officer

CADLSell · Jul 1, 2026

Seshu Tyagarajan

officer: Chief Technology Officer

CADLSell · Jul 1, 2026

Paul B Manning

director

CADLBuy · Feb 26, 2026

William Garrett Nichols

Chief Medical Officer

CADLSell · Jul 28, 2025

Explore More Insider Trading Data

CADL Insider Trading Activity

View all insider trades at Candel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity